These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16862806)

  • 61. Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia.
    Kangussu-Marcolino MM; Ehrenkaufer GM; Chen E; Debnath A; Singh U
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():80-94. PubMed ID: 31707263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A rare but fatal case of granulomatous amebic encephalitis with brain abscess: the first case reported from Turkey.
    Sarica FB; Tufan K; Cekinmez M; Erdoğan B; Altinörs MN
    Turk Neurosurg; 2009 Jul; 19(3):256-9. PubMed ID: 19621290
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PLGA nanoparticles loaded with Gallic acid- a constituent of Leea indica against Acanthamoeba triangularis.
    Mahboob T; Nawaz M; de Lourdes Pereira M; Tian-Chye T; Samudi C; Sekaran SD; Wiart C; Nissapatorn V
    Sci Rep; 2020 Jun; 10(1):8954. PubMed ID: 32488154
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of antibodies against free-living amoebae Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis.
    Schuster FL; Honarmand S; Visvesvara GS; Glaser CA
    Clin Infect Dis; 2006 May; 42(9):1260-5. PubMed ID: 16586385
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro acanthamoebicidal activity of fusaric acid and dehydrofusaric acid from an endophytic fungus Fusarium sp. Tlau3.
    Boonman N; Prachya S; Boonmee A; Kittakoop P; Wiyakrutta S; Sriubolmas N; Warit S; Dharmkrong-At Chusattayanond A
    Planta Med; 2012 Sep; 78(14):1562-7. PubMed ID: 22864988
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Encystation in Acanthamoeba castellanii: development of biocide resistance.
    Lloyd D; Turner NA; Khunkitti W; Hann AC; Furr JR; Russell AD
    J Eukaryot Microbiol; 2001; 48(1):11-6. PubMed ID: 11249185
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Minimal Cerebrospinal Fluid Concentration of Miltefosine despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis.
    Monogue ML; Watson D; Alexander JS; Cavuoti D; Doyle LM; Wang MZ; Prokesch BC
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685474
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The increasing importance of Acanthamoeba infections.
    Marciano-Cabral F; Puffenbarger R; Cabral GA
    J Eukaryot Microbiol; 2000; 47(1):29-36. PubMed ID: 10651293
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery of Amoebicidal Compounds by Combining Computational and Experimental Approaches.
    Sebastián-Pérez V; Sifaoui I; Reyes-Batlle M; Domínguez-De Barros A; López-Arencibia A; Campillo NE; Piñero JE; Lorenzo-Morales J; Gil C
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229426
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Derivatisation of metronidazole enhances cytotoxic effect against Acanthamoeba genotype T4 isolates and leads to cytomorphological changes in trophozoites.
    Dušeková A; Garajová M; Lukáč M; Mrva M
    Acta Trop; 2021 Apr; 216():105830. PubMed ID: 33465352
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis.
    Dudley R; Alsam S; Khan NA
    Appl Microbiol Biotechnol; 2007 May; 75(1):133-40. PubMed ID: 17225099
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
    Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activity of isoflavans of Dalea aurea (Fabaceae) against the opportunistic ameba naegleria fowleri.
    Belofsky G; Carreno R; Goswick SM; John DT
    Planta Med; 2006 Mar; 72(4):383-6. PubMed ID: 16557484
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In Vitro Amoebicidal Activity of Imidazolium Salts Against Trophozoites.
    Fabres LF; da Costa Gonçalves F; Duarte EOS; Berté FK; da Conceição DKSL; Ferreira LA; Schrekker HS; Rott MB
    Acta Parasitol; 2020 Jun; 65(2):317-326. PubMed ID: 31939031
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro activity of 1H-phenalen-1-one derivatives against Acanthamoeba castellanii Neff and their mechanisms of cell death.
    López-Arencibia A; Reyes-Batlle M; Freijo MB; McNaughton-Smith G; Martín-Rodríguez P; Fernández-Pérez L; Sifaoui I; Wagner C; García-Méndez AB; Liendo AR; Bethencourt-Estrella CJ; Abad-Grillo T; Piñero JE; Lorenzo-Morales J
    Exp Parasitol; 2017 Dec; 183():218-223. PubMed ID: 28916457
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro drug susceptibility of Acanthamoeba castellani to chloroquine, ivermectin and fungizon.
    Rain AN; Radzan T; Sajiri S; Mak JW
    Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):319-24. PubMed ID: 9279996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of pathogenic potential of Acanthamoeba isolates by in vitro and in vivo tests.
    Sharma C; Khurana S; Megha K; Thakur A; Bhatia A; Gupta A
    Parasitol Res; 2023 Sep; 122(9):2109-2118. PubMed ID: 37418019
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Case Report: Granulomatous Amebic Encephalitis due to Acanthamoeba spp. in an Immunocompetent Pediatric Patient.
    Aparicio DV; Bejarano JIC; de Los Santos AM; Ramírez-Cortinas S; de la O Cavazos M
    Am J Trop Med Hyg; 2021 May; 105(1):167-170. PubMed ID: 33970886
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii.
    Mattana A; Biancu G; Alberti L; Accardo A; Delogu G; Fiori PL; Cappuccinelli P
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4520-7. PubMed ID: 15561820
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient.
    Walia R; Montoya JG; Visvesvera GS; Booton GC; Doyle RL
    Transpl Infect Dis; 2007 Mar; 9(1):51-4. PubMed ID: 17313473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.